| scholarly article | Q13442814 |
| P2093 | author name string | J Y Wang | |
| G Losonsky | |||
| M M Levine | |||
| F R Noriega | |||
| S B Formal | |||
| P2860 | cites work | ??? | Q94264873 |
| Escherichia coli that cause diarrhea: enterotoxigenic, enteropathogenic, enteroinvasive, enterohemorrhagic, and enteroadherent | Q33453483 | ||
| Immunity to Enterotoxigenic Escherichia coli | Q34080152 | ||
| Construction and characterization of attenuated delta aroA delta virG Shigella flexneri 2a strain CVD 1203, a prototype live oral vaccine | Q34545910 | ||
| Prospects for Human Mucosal Vaccines | Q35210784 | ||
| Purification and analysis of colonization factor antigen I, coli surface antigen 1, and coli surface antigen 3 fimbriae from enterotoxigenic Escherichia coli | Q36184473 | ||
| Escherichia coli strains that cause diarrhoea but do not produce heat-labile or heat-stable enterotoxins and are non-invasive | Q39488888 | ||
| Immunogenicity and efficacy of oral or intranasal Shigella flexneri 2a and Shigella sonnei proteosome-lipopolysaccharide vaccines in animal models. | Q40267400 | ||
| Experimental Shigella infections: characteristics of a fatal infection produced in guinea pigs. | Q40314454 | ||
| Evaluation of the safety, immunogenicity, and efficacy in healthy adults of four doses of live oral hybrid Escherichia coli-Shigella flexneri 2a vaccine strain EcSf2a-2 | Q40687041 | ||
| Advances in influenza virus vaccine research | Q40841606 | ||
| Simultaneous expression of CFA/I and CS3 colonization factor antigens of enterotoxigenic Escherichia coli by delta aroC, delta aroD Salmonella typhi vaccine strain CVD 908. | Q50143254 | ||
| Adenovirus vectored vaccines. | Q52846854 | ||
| Systemic and mucosal immunity induced by BCG vector expressing outer-surface protein A of Borrelia burgdorferi | Q59098578 | ||
| The response of man to virulent Shigella flexneri 2a | Q72377709 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Escherichia coli | Q25419 |
| vaccine | Q134808 | ||
| Shigella flexneri | Q1644417 | ||
| P304 | page(s) | 23-27 | |
| P577 | publication date | 1996-01-01 | |
| P1433 | published in | Infection and Immunity | Q6029193 |
| P1476 | title | Further characterization of delta aroA delta virG Shigella flexneri 2a strain CVD 1203 as a mucosal Shigella vaccine and as a live-vector vaccine for delivering antigens of enterotoxigenic Escherichia coli | |
| P478 | volume | 64 |
| Q34941041 | Analysis of virulence and inflammatory potential of Shigella flexneri purine biosynthesis mutants |
| Q39519924 | Attenuated Shigella flexneri 2a Delta guaBA strain CVD 1204 expressing enterotoxigenic Escherichia coli (ETEC) CS2 and CS3 fimbriae as a live mucosal vaccine against Shigella and ETEC infection |
| Q33597022 | Attenuated Shigella flexneri 2a vaccine strain CVD 1204 expressing colonization factor antigen I and mutant heat-labile enterotoxin of enterotoxigenic Escherichia coli |
| Q34007802 | Constitutive expression of the Vi polysaccharide capsular antigen in attenuated Salmonella enterica serovar typhi oral vaccine strain CVD 909 |
| Q33558374 | Construction and characterization of bivalent Shigella flexneri 2a vaccine strains SC608(pCFAI) and SC608(pCFAI/LTB) that express antigens from enterotoxigenic Escherichia coli |
| Q34008449 | Construction, genotypic and phenotypic characterization, and immunogenicity of attenuated DeltaguaBA Salmonella enterica serovar Typhi strain CVD 915. |
| Q35510455 | Engineered deltaguaB-A deltavirG Shigella flexneri 2a strain CVD 1205: construction, safety, immunogenicity, and potential efficacy as a mucosal vaccine |
| Q33558850 | Enhanced immunoglobulin A response and protection against Salmonella enterica serovar typhimurium in the absence of the substance P receptor |
| Q35896020 | Enteric pathogens as vaccine vectors for foreign antigen delivery |
| Q34008065 | EspG, a novel type III system-secreted protein from enteropathogenic Escherichia coli with similarities to VirA of Shigella flexneri |
| Q39509333 | Establishment of unipolar localization of IcsA in Shigella flexneri 2a is not dependent on virulence plasmid determinants |
| Q34716080 | Genetic characterization and immunogenicity of coli surface antigen 4 from enterotoxigenic Escherichia coli when it is expressed in a Shigella live-vector strain |
| Q33747425 | Immunogenicity of IpaC-hybrid proteins expressed in the Shigella flexneri 2a vaccine candidate SC602 |
| Q35598035 | Live attenuated Shigella dysenteriae type 1 vaccine strains overexpressing shiga toxin B subunit |
| Q34006071 | Parameters underlying successful protection with live attenuated mutants in experimental shigellosis |
| Q35528270 | Safety, immunogenicity, and transmissibility in humans of CVD 1203, a live oral Shigella flexneri 2a vaccine candidate attenuated by deletions in aroA and virG. |
| Q40905058 | Simple method for purification of enterotoxigenic Escherichia coli fimbriae |
| Q34000330 | Strategy for cross-protection among Shigella flexneri serotypes |
| Q35229428 | Vibriocidal antibody responses in North American volunteers exposed to wild-type or vaccine Vibrio cholerae O139: specificity and relevance to immunity |
Search more.